Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
09/2003
09/18/2003WO2003076438A1 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076432A1 Benzodiazepine-substituted piperidines for utilization in the treatment of cardiovascular diseases
09/18/2003WO2003076430A1 Amino-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076427A1 Quinazoline compounds useful in therapy
09/18/2003WO2003076421A1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076417A2 Oxo-azabicyclic compounds
09/18/2003WO2003076416A1 Oxo azabicyclic compounds
09/18/2003WO2003076408A2 Indazole derivatives that are activators of soluble guanylate cyclase
09/18/2003WO2003076400A1 New inhibitors of histone deacetylase
09/18/2003WO2003076398A2 Pyrrole-2, 5-dione derivatives and their use as gsk-3 inhibitors
09/18/2003WO2003076395A1 Carbonylamino-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003075929A1 Inhibitors of histone deacetylase
09/18/2003WO2003053368A3 Chalcone derivatives and their use to treat diseases
09/18/2003WO2003051838A3 Protein kinase inhibitors
09/18/2003WO2003049681A3 Synthesis of 4,5-dihydro-pyrazolo [3,4-c] pyrid-2-ones
09/18/2003WO2003029340A3 Fluorescent pigment composition
09/18/2003WO2002034745A8 Chemokine receptor binding heterocyclic compounds
09/18/2003US20030176702 N-(azabicyclo moieties)-substituted hetero-bicyclic aromatic compounds for the treatment of disease
09/18/2003US20030176701 Di-or triaza-spiro [4,5] decane derivatives
09/18/2003US20030176700 Process for preparing 2-(4-pyridyl)amino-6-dialkyloxyphenyl-pyrido(2,3-d)pyrimidin-7-ones
09/18/2003US20030176694 Fused heterocyclic compounds
09/18/2003US20030176670 Multivalent macrolide antibiotics
09/18/2003US20030176458 Urea substituted imidazopyridines
09/18/2003US20030176454 N-coating heterocyclic compounds
09/18/2003US20030176451 Reacting a heterocyclic-methanesulfonyl substituted-quinazolineamine compound with amine compound
09/18/2003US20030176443 Pyridylpyrimidine derivatives as effective compounds against prion diseases
09/18/2003US20030176438 Useful as adjuvants to chemotherapy or radiation therapy in the treatment of cancer; as inhibitors of checkpoint kinase Cds1 (in man also known as Chk2)
09/18/2003US20030176436 For therapy and prophylaxis of bacterial infections, or their use as antiseptics, sterilizants, or disinfectants
09/18/2003US20030176435 Binding to the NMDA receptor glycine site have utility for the amelioration of pain and particularly for amelioration of neuropathic pain
09/18/2003US20030176434 Compounds and methods for promoting smoking cessation
09/18/2003US20030176433 For therapy and prophylaxis of hepatitis C virus (HCV) infection
09/18/2003US20030176432 Cyclic and heterocyclic N-substituted alpha-iminohydroxamic and -carboxylic acids
09/18/2003US20030176422 Pyridoarylphenyl oxazolidinone antibacterials, and related compositions and methods
09/18/2003US20030176416 For therapy of disease, disorder or condition is responsive to modulation of cholinergic receptors and/or monoamine receptors
09/18/2003US20030176401 Sodium salt of an azo derivative of 5-aminosalicylic acid
09/18/2003CA2482191A1 Spiro compounds with npy antagonistic activity
09/18/2003CA2479016A1 Quinazoline compounds useful in therapy
09/18/2003CA2478706A1 Oxo-azabicyclic compounds
09/18/2003CA2477984A1 Pyrrole-2, 5-dione derivatives and their use as gsk-3 inhibitors
09/18/2003CA2476031A1 Novel substituted piperidines, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof
09/17/2003EP1343791A2 Substituted tetracyclic pyridoindoles as serotonin agonists and antagonists
09/17/2003EP1343789A1 Tricyclic derivatives of indole with antiangiogenic activity
09/17/2003EP1343786A1 Novel pyridine-substituted pyrazolopyridine derivatives
09/17/2003EP1343785A2 Use of substituted imidazoazines, novel imidazoazines, methods for the production thereof, and agents containing these compounds
09/17/2003EP1343784A2 Urea substituted imidazoquinoline ethers
09/17/2003EP1343783A2 Substituted imidazopyridines
09/17/2003EP1343780A1 Piperazine derivatives for treatment of bacterial infections
09/17/2003EP1343768A1 Aryl and aminoaryl substituted serotonin receptor agonist and antagonist ligands
09/17/2003EP1343766A1 Cyclization process step in the making of quinolones and naphthyridines
09/17/2003EP1343505A1 Cxcr3 antagonists
09/17/2003EP1343499A2 Heterocyclic substituted 2-methyl-benzimidazole antiviral agents
09/17/2003EP1282622B1 Crf receptor antagonists and methods relating thereto
09/17/2003EP0910566B1 Heterocyclic compounds and their preparation and use
09/17/2003CN1121376C Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives and matrix metalloprotease inhibitors
09/16/2003US6620937 Intermediates in the synthesis of camptothecin and related compounds and synthesis thereof
09/16/2003US6620820 Inhibitors of bone reabsorption and antagonists of vitronectin receptors
09/16/2003US6620812 Sulfamoyl compounds and agricultural and horticultural fungicides
09/16/2003US6620807 Pyridobenzodiazepine and pyridobenzoxazepine carboxyamide vasopressin agonists
09/16/2003US6620529 Dyes for filters, color conversion filters, photographic material dyes, sensitizing dyes, dyes for dying pulp, laser dyes, fluorescent drugs for medical diagnoses and materials for light emitting devices, and light emitting devices using
09/16/2003CA2283671C Salt of naphthyridine carboxylic acid derivative
09/16/2003CA2232116C Novel n-aryl piperidine compounds, process for their preparation and pharmaceutical compositions containing them
09/16/2003CA2215695C .beta.-sheet mimetics and use thereof as protease inhibitors
09/16/2003CA2078759C Novel carboxyalkyl derivatives useful as inhibitors of enkephalinase and ace
09/16/2003CA2047857C (quinolin-2-ylmethoxy)heterotetrahydrocarbazoles as inhibitors of the biosynthesis of leukotrienes
09/12/2003WO2003074539A1 Cycloamide-transition metal complexes and bleach catalysts
09/12/2003WO2003074524A2 Mappicine analogs, intermediates in the synthesis of mappicine analogs and methods of synthesis of mappicine analogs
09/12/2003WO2003074523A2 Gadolinium chelate oligomers, their use as contrast products in magnetic resonance imaging and their synthesis intermediates
09/12/2003WO2003074522A1 Process for preparing 3-(2-(4-(6-fluorobenzo(d) isoxazol-3-yl)-piperidin-1yl)-ethyl)-2-methyl-6,7,8,9-tetrahydro-4h-pyrido-(1,2-a) pyrimidin-4-one
09/12/2003WO2003074519A1 Coumarines useful as biomarkers
09/12/2003WO2003074508A1 Compounds and methods of treating cell proliferative diseases
09/12/2003WO2003074489A1 Cyclic n-substituted alpha iminocarboxylic acids for selectively inhibiting collagenase
09/12/2003WO2003048081A3 Glycinamides as factor xa inhibitors
09/12/2003WO2003045942A3 Chemokine receptor antagonists and methods of use thereof
09/12/2003WO2003034987A3 Androgen receptor modulators and methods of use thereof
09/12/2003WO2003024963A3 Substituted imidazo[1, 2-a]-5, 6, 7,8-tetrahydropyridine-8-ones, method for their production and the use thereof for producing imidazo[1, 2-a]pyridines
09/12/2003WO2002058695A9 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents
09/12/2003WO2002040486A3 METHODS OF TREATING p38 KINASE-ASSOCIATED CONDITIONS AND PYRROLOTRIAZINE COMPOUNDS USEFUL AS KINASE INHIBITORS
09/12/2003WO2002009683A3 Aldosterone blocker therapy to prevent or treat inflammation-related disorders
09/12/2003WO2002004443A3 Heterocycle carboxamides as antiviral agents
09/12/2003CA2477003A1 Compounds and methods of treating cell proliferative diseases
09/12/2003CA2474811A1 Process for preparing 3-(2-(4-(6-fluorobenzo(d) isoxazol-3-yl)-piperidin-1yl)-ethyl)-2-methyl-6,7,8,9-tetrahydro-4h-pyrido-(1,2-a) pyrimidin-4-one
09/12/2003CA2472298A1 Coumarines useful as biomarkers
09/11/2003US20030171584 6-Substituted pyrido-pyrimidines
09/11/2003US20030171396 Sulfonamide compounds and uses thereof as medicines
09/11/2003US20030171395 Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands
09/11/2003US20030171394 Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers
09/11/2003US20030171392 Substituted indeno[1,2-c]isoquinoline derivatives and methods of use thereof
09/11/2003US20030171373 Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation
09/11/2003US20030171368 Compounds which bind to integrin receptors; treatment of thromboembolic events, cardiovascular diseases, pulmonary diseases, tumors, gastrointestinal diseases
09/11/2003US20030171366 Having antibacterial activity against Gram-positive and Gram-negative bacteria
09/11/2003US20030171363 Non-nucleoside reverse transcriptase inhibitors
09/11/2003US20030171359 Suitable for treatment of illnesses characterised by excessive or abnormal cell proliferation; viral, bacterial, fungal and/or parasitic infections, skin diseases, bone diseases, cardiovascular diseases
09/11/2003US20030171358 New compounds, their preparation and use
09/11/2003US20030171357 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
09/11/2003US20030171355 For modulating the activity of a G-protein-coupled receptor or a sigma receptor in a mammal; for treating inflammatory pain, neuropathic pain, multiple sclerosis, anxiety, depression, psychosis, stroke, motor neuron disease
09/11/2003US20030171353 Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands
09/11/2003US20030171347 Sigma receptor antagonist compounds that have anti-cocaine properties. These sigma receptor antagonists are useful in the treatment of cocaine overdose and addiction as well as movement disorders. The sigma receptor antagonists of the
09/10/2003EP1341793A2 Crf receptor antagonists and methods relating thereto
09/10/2003EP1341792A2 Amido ether substituted imidazoquinolines
09/10/2003EP1341791A2 Thioether substituted imidazoquinolines
1 ... 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 ... 646